Phase II study on cisplatin and ifosfamide in recurrent high grade gliomas
- 30 September 1998
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 34 (10) , 1570-1574
- https://doi.org/10.1016/s0959-8049(98)00138-5
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pharmacokinetic-dynamic relationship of cisplatin in vitro: simulation of an i.v. bolus and 3 h and 20 h infusionBritish Journal of Cancer, 1994
- A phase I trial of ifosfamide, mesna, and cisplatin in advanced non-small cell lung cancer a cancer and leukemia group B studyCancer, 1993
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer, 1993
- Phase II evaluation of high-dose intravenous cisplatin for treatment of adult malignant gliomas recurrent after chloroethylnitrosourea failureJournal of Neuro-Oncology, 1992
- Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanomaAnnals of Oncology, 1990
- Reoperation for malignant astrocytomaNeurology, 1989
- A study of cis-platinum and ifosfamide in alkylating agent-resistant ovarian cancerGynecologic Oncology, 1989
- Reoperation in the Treatment of Recurrent Intracranial Malignant GliomasNeurosurgery, 1987
- Phase II study of cisplatin in recurrent astrocytomas in adults: A southwest oncology group studyJournal of Neuro-Oncology, 1983
- Combination chemotherapy with ifosfamide and cis-dichlorodiammineplatinum (II) in advanced malignant melanomaZeitschrift für Krebsforschung und Klinische Onkologie, 1980